South San Francisco, CA June 30, 2018 Press Release Genentech’s TECENTRIQ in Combination with Chemotherapy Helped People with Previously-Untreated Extensive-Stage Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy –IMpower133 is the first Phase III study with an immunotherapy-based…